This is a profile image of Matt Wilson

Matt Wilson

Senior PartnerNew York

Brings extensive expertise across the healthcare sector; currently helping to lead McKinsey’s global client response to COVID-19

Matthew Wilson is a senior partner in McKinsey’s New York office, where he has spent the last 15 years. He works across healthcare, serving clients across the public, private, and social sectors. His clients include a mix of biotechs and pharma, governments, foundations, private equity firms, academic medical centers, public private partnerships, and healthcare services companies. He is passionate about using R&D and innovation to transform healthcare and improve patient outcomes around the world.

Matt leads McKinsey’s work in public health and has served more than 15 governments across the world, covering a wide range of topics including infectious disease management, immunization, health system management, and innovation. He is currently helping to lead McKinsey’s global client response to COVID-19, coordinating a global team of experts in public health, crisis response, supply chain, and economics to support the public health response and help organizations manage their own response.

Matt serves on the board of Brooklyn Museum and is a member of the Council on Foreign Relations.

Published work

Public health’s inflection point with generative AI,” McKinsey & Company, February 2024

Future-proofing health systems for climate risks and pandemics,” McKinsey & Company, December 2023

How digital tools could boost efficiency in African health systems,” McKinsey & Company, March 2023

Measuring preparedness: Are public health systems ready for the next pandemic?,” McKinsey & Company, October 2022

The gathering storm: The affordability challenge of endemic COVID-19,” McKinsey & Company, September 2022

When will the COVID-19 pandemic end?,” McKinsey & Company, July 2022

Care for the caretakers: Building the global public health workforce,” McKinsey & Company, July 2022

Ten lessons from the first two years of COVID-19,” McKinsey & Company, March 2022

When will the COVID-19 pandemic end?,” McKinsey & Company, March 2022

When will the COVID-19 pandemic end?,” McKinsey & Company, December 2021

Unlocking digital healthcare in lower- and middle-income countries,” McKinsey & Company, November 2021

Pandemic to endemic: How the world can learn to live with COVID-19,” McKinsey & Company, October 2021

When will the COVID-19 pandemic end?,” McKinsey & Company, August 2021

The future of Emergency Operation Centers: Six shifts to consider from COVID-19,” McKinsey & Company, July 2021

All in the mix: Why US COVID-19 cases rose and fell, and what comes next,” McKinsey & Company, March 2021

When will the COVID-19 pandemic end?,” McKinsey & Company, March 2021

Forum Spotlight: Global health in the post-COVID-19 era,” Bloomberg New Economy Forum, Fall 2020

The global response to AMR: momentum, success, and critical gaps, Wellcome, November 2020

When will the COVID-19 pandemic end?,” McKinsey & Company, September 2020

COVID-19: Implications for business,” McKinsey & Company, August 2020

How investing in health has a significant economic payoff for developing economies,” Brookings Institution, July 2020

Ten innovations that can improve global health,” McKinsey Global Institute, July 2020

Not the last pandemic: Investing now to reimagine public-health systems,” McKinsey & Company, July 2020

Prioritizing health: A prescription for prosperity,” McKinsey Global Institute, July 2020

Return: A new muscle, not just a plan,” McKinsey & Company, May 2020

Crushing coronavirus uncertainty: The big ‘unlock’ for our economies,” McKinsey & Company, May 2020

Contact tracing for COVID-19: New considerations for its practical application,” McKinsey & Company, May 2020

How to restart national economies during the coronavirus crisis,” McKinsey & Company, April 2020

Education

Yale University
BA, economics, mathematics